Discussion
Main findings
This large-scale study, conducted across four sites with six datasets, included 497 SZPs and 374 HCs. The groups were age-matched and gender-matched, but SZPs had lower educational levels. The majority of SZPs presented mild-to-moderate severity of schizophrenia symptoms, accompanied by cognitive impairments across various domains. Notably, abnormal TP-FCs and A-TP-SCs were identified in SZPs.
Global network metrics
Sigma, Gamma and Lambda are metrics related to random networks (Sigma=Gamma/Lambda, Gamma=Cp of real brain networks/Cp of random networks and Lambda=Lp of real brain networks/Lp of random networks).1 Random networks mirror the same number of nodes, edges and degree distribution as actual brain networks.1 Our investigation indicates that SZPs maintain small-worldness (Sigma>1.1) compared with randomly generated networks and show no significant difference from HCs in small-worldness.1 Moreover, SZPs exhibited no significant difference from HCs in AUC for Gamma and Gamma within each sparsity network; however, a lower AUC for Lambda and lower Lambda in certain sparsity networks were observed. Gamma and Lambda represent the efficiency of FS and FI, respectively, in actual brain networks based on existing nodes, edges and degree distribution according to the formula.1 Therefore, patients exhibited no difference with HCs in the efficiency of FS but had higher efficiency in FI. This observation suggests a compensatory increase in the efficiency of FS under pathological conditions.
Furthermore, compared with HCs, SZPs showed no significant difference in AUC for Lp and Eg, as well as these metrics across all sparsity networks. Lp and Eg represent measures of global FI.1 Thus, SZPs demonstrated equivalent global FI capabilities with HCs, and the measurement methods confirmed each other. However, SZPs exhibited decreased AUC for Cp and Eloc, as well as Cp in some sparsity networks. Cp and Eloc represent measures of global FS.1 Thus, relative to HCs, SZPs showed a reduced ability for global FS, and the measurement methods confirmed each other. However, SZPs and HCs exhibited no difference in AUC for the number of modules and modularity, as well as these metrics across all sparsity networks. Modular architecture, also a measure of FS,8 was retained by SZPs. However, despite maintaining a functional network modular architecture, SZPs demonstrated lower clustering and local information communication. Moreover, SZPs exhibited increased AUC for synchronisation, hierarchy and Z-score of hierarchy, as well as synchronisation in certain sparsity networks. These metrics assess the tendency of all nodes to fluctuate or oscillate in the same wave pattern.2 Therefore, nodes in SZPs are more prone to fluctuations or oscillation within the same wave pattern than those in HCs, suggesting a decreased capacity for specialised processes.13 FS refers to the specialised processing capacity within closely connected groups of brain regions.1 Therefore, the decreased Cp and Eloc, accompanied by increased synchronisation and hierarchy, consistently highlight the presence of reduced global FS in SZPs. Compared with HCs, SZPs exhibited lower assortativity and Z-score of assortativity, as well as Z-score of assortativity in certain sparsity networks. Assortativity, which assesses the correlation between the degrees of nodes at opposite ends of an edge, serves as a metric for evaluating the resilience of functional networks.1 2 Thus, SZPs demonstrated reduced resilience in functional networks, rendering them more susceptible to insult.1
In summarising the global network perspective findings, SZPs exhibited preserved small-worldness and global FI capabilities. However, a notable impairment was observed in the ability of global FS and resilience against external perturbations.
Nodal network metrics
Both Dc and Ne assess nodal capacity for FI.1 SZPs showed altered AUC for Dc and Ne in nearly the same brain areas. Consequently, these metrics mutually supported each other, suggesting a decreased nodal capacity for FI in the sensory areas and a compensatory increase in the cognition and information integration areas of SZPs. Both NCp and NLe measure nodal capacity for FS.1 SZPs showed decreased AUC for these metrics in almost the same brain areas. Thus, the findings in the two metrics confirmed each other, suggesting that SZPs had decreased nodal capacity for FS in the sensory areas. Furthermore, the findings in Bc and NLp further verified these conclusions.
In summarising the nodal network perspective findings, SZPs exhibited reduced nodal capacity for FI and FS in the sensory areas, accompanied by a compensatory increase in nodal capacity for FI in the cognition and information integration areas.
Associations between TP-FCS and symptoms or cognitions
Despite the enhanced synchronisation in SZPs than HCs, the negative correlation between the AUC for synchronisation and the severity of positive symptoms in SZPs suggests that this heightened synchronisation may serve as a resistance or compensatory mechanism against the exacerbation of positive symptoms among SZPs. An association was also determined between increased negative symptoms and decreased Eg, together with reduced Bc in the right gyrus rectus. This finding suggests that negative symptoms in patients may result from a reduction in the efficiency of global information communication and a decrease in the effect of the right gyrus rectus on the flow of information between other nodes.5 6 9
We found that global network metrics (including Cp, Eloc, assortativity, hierarchy, Gamma and Lambda) and nodal network metrics (including Bc and NLe) were associated with cognitive functions (including the speed of processing, visual learning and the ability to inhibit cognitive interference) in SZPs. Moreover, SZPs exhibited decreased Cp, Eloc and assortativity, as well as increased hierarchy. Consequently, the observed A-TP-SCs indicate that decreased global FS and resilience in functional networks are pathological impairments in schizophrenia.6–8
Limitations
A notable strength of this study lies in its distinction as the first large-scale exploration of TP-FCs and A-TP-SCs in SZPs. The observed correlation coefficients ranged from 0.08 to 0.26, with most coefficients below 0.2. Consequently, the minimum sample size of 200 SZPs might not adequately identify A-TP-SC in SZPs.12 Another strength is evident in the high consistency of results concerning TP-FCs, measuring the same attribute of the functional connectomes. In addition, there are consistently observed associations between diminished cognitive functions and decreased FS and resilience in SZPs. These robustly support the conclusions of this study.
However, we did not explore factors (eg, age, gender, economic status, geographical source and antipsychotic use) affecting SZP topology because of the subgroup sample size requirement of more than 200 SZPs. SZPs and HCs in this study were age-matched and gender-matched, but SZPs exhibited a lower educational level, consistent with real-world reports. The predominant age distribution of patients corresponds to the predominant age range of SZPs in China (18–34 years).23 To verify whether including patients in the rapid developmental phase of adolescence, specifically those aged 12–16, impacted the study results, we excluded patients and HCs of this age group (43 SZPs and 31 HCs). The results remained consistent with those of all subjects. Thus, including patients and HCs aged 12–16 did not impact the study results. However, since the number of patients and HCs aged 12–16 in this study was relatively small, we cannot determine whether age or development might influence the TP-FCs, or whether there are any differences in TP-FCs between adolescents and adults. A previous study found that nodal characteristics such as betweenness centrality decreased, while degree centrality and nodal efficiency increased with age in healthy Chinese participants.24 Therefore, age and development may influence the TP-FCs. While no significant gender difference was observed between SZPs and HCs, the patient group had a higher proportion of women. This discrepancy is attributed to dataset E recruiting more women than men, contrasting with approximate headcount and schizophrenia prevalences in both genders in China.23 A recent meta-analysis revealed a gender influence on Eloc in SZPs,4 emphasising the need for further research on gender impact on TP-FCs in SZPs.25 Sourced from four cities (three datasets from Xinxiang and one each from Nanjing, Changsha and Foshan), the data encompass the northern, central and southern regions of China. Notably, the dataset lacks representation from the economically disadvantaged western regions of China. Previous studies on TP-FCs in SZPs did not consider economic factors; nonetheless, the impact of the economy on TP-FCs in China needs to be explored because of its recognised effects on other functional brain metrics.26 Moreover, the geographical source potentially includes many factors such as economy, culture and environment that may influence the TP-FC results.27 However, with the current sample, we were unable to explore this issue. Analysing the data separately from each site would drastically reduce the sample size, thereby significantly compromising statistical power. Thus, with the current sample, the consistency of results across different data sources would not adequately address whether the geographical source of the data may influence the TP-FC results. Future multicentre studies with large samples at each site are needed to explore the influence of the geographical source of the data on the TP-FCs. A recent meta-analysis underscored topology disparities in structural connectome studies between untreated SZPs and those with antipsychotic use.4 However, the effect of antipsychotic use on TP-FCs was not evaluated in the meta-analysis because of data limitations. The current study includes both drug-naive and antipsychotic-exposed SZPs, emphasising the need for further research into the influence of antipsychotic use on TP-FCs.
Implications
In summary, this large-scale study investigated TP-FCs and A-TP-SCs in SZPs. Analysis of global network metrics revealed that SZPs maintained small-worldness and global FI capacity, despite compromised global FS and resilience against insults. Exploring nodal network metrics, we observed a reduction in nodal FI and FS capacity in the sensory areas of SZPs. Conversely, a compensatory increase in nodal FI capacity was found in areas associated with cognition and information integration. A-TP-SCs were identified, confirming that the diminished FS and resilience are pathological impairments in schizophrenia. The results of A-TP-SCs or TP-FCs, which measure the same attribute of the functional connectomes, are highly internally unified, supporting the findings of this study.
Furthermore, several potential clinical implications and guidance for the treatment and intervention of SZPs can be drawn from these findings. First, targeted interventions for specific brain regions showing abnormal TP-FCs are recommended. Neuromodulation techniques, such as transcranial magnetic stimulation or transcranial direct current stimulation, might be used to modulate brain network connectivity and potentially improve TP-FCs.28 29 Second, personalised treatment plans should be developed. Assessments of TP-FCs might be incorporated into the diagnostic and monitoring process to help create individualised treatment plans.30 Furthermore, symptom-specific approaches should be considered to address the symptoms and cognitive deficits associated with diminished functional segregation and resilience. Third, changes in TP-FCs may be used to monitor treatment effects. For instance, improvements in TP-FCs following pharmacological treatment or cognitive therapy could be quantified, providing objective measures of treatment efficacy. Lastly, further research into the mechanisms underlying diminished functional segregation and resilience in schizophrenia will facilitate the development of more targeted and effective treatments. Supporting the development of innovative therapies aimed at enhancing brain functional segregation and resilience could potentially lead to new treatment avenues. By integrating these insights into clinical practice, healthcare providers can improve the effectiveness of treatments for schizophrenia, leading to better management of symptoms and enhanced cognitive functioning for SZPs.